Maze Therapeutics: CEO Jason V Coloma sold 34,501 shares

What happened

• Jason V Coloma, CEO, sold 34,501 shares in two transactions on Oct 01, 2026, for total proceeds of $932,259. He sold 2,593 shares at $27.02 for $70,073 and 31,908 shares at $27.02 for $862,186.

Key details

• Transaction date: Oct 01, 2026.
• Transactions: sale code S (open market or private sale).
• Reported prices: column price shown as $27.02; footnotes report weighted average ranges of $26.645 to $27.46 (F2) and $26.585 to $27.47 (F4).
• Shares owned after the transaction: not reported in the provided filing excerpt.
• Footnotes of note: the sales were effected under a Rule 10b5-1 trading plan adopted Feb 06, 2026 (F1); some securities are directly held by The Coloma 2021 Irrevocable Trust (F3) and the Coloma Family Trust (F5).
• Form 4 filed on Oct 02, 2026. No late filing is indicated in the provided data.

Why it may matter

• These were market sales (code S), not option exercises or gifts.
• Some of the sold securities were held in trusts for which the reporting person and his spouse serve as co-trustees (F3, F5).
• The sales were executed pursuant to a Rule 10b5-1 plan (F1).
• A filing does not show why the insider traded or why the company acted.